在性结肠炎中定位治疗的实用方法
Russell Yanofsky1, David T Rubin1
1The University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, United States.
本综述为选择和排序性结肠炎 (UC) 治疗提供了一个框架. 它探讨了改善UC患者长期缓解率的挑战和未来方向.
科学领域:
- 胃肠病学 胃肠病学
- 内部医学 内部医学
背景情况:
- 性结肠炎 (UC) 的治疗环境已经发生了显著的变化.
- 尽管有新的治疗方法,但由于复杂的治疗策略,在UC中实现长期缓解仍然具有挑战性.
研究的目的:
- 提出一个合理的框架,以优化性结肠炎患者的治疗选择和顺序.
- 概述UC管理的治疗目标和目标.
主要方法:
- 关于性结肠炎治疗的当前文献的综述.
- 分析影响治疗选择的因素,包括疗效,安全性,交付,获取和患者特异性考虑.
- 深入检查已批准的UC疗法,详细说明其优缺点.
主要成果:
- 介绍了UC治疗选择和测序的结构化方法.
- 确定了指导治疗策略的关键考虑因素.
- 目前的UC疗法被评估为它们的优点和缺点.
结论:
- 未来的UC管理可能包括自然疗法,便微生物群治疗和精准医学.
- 组合疗法和个性化方法是改善UC结果的有希望的方向.
更多相关视频
07:38Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
Published on: September 13, 2016
07:05Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
